Stock Events

Stock Events

Creative Medical Technology 

$2.05
24
+$0.06+3.19% Thursday 20:00

Statistics

Day High
2.1
Day Low
1.95
52W High
6.25
52W Low
1.5
Volume
3,717
Avg. Volume
64,559
Mkt Cap
5.3M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3JunExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-1.09
-0.85
-0.61
-0.37
Expected EPS
N/A
Actual EPS
N/A

Financials

-49,936.36%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
22,000Revenue
-10.99MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CELZ. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Mimedx Group
MDXG
Mkt Cap1.13B
MiMedx Group, Inc. specializes in regenerative biomaterials, a field closely related to Creative Medical's focus on regenerative medicine, making them direct competitors in the market for healing and regeneration solutions.
Mesoblast
MESO
Mkt Cap2.14B
Mesoblast Limited focuses on regenerative medicine using its proprietary mesenchymal lineage cell therapy technology, competing in the same space as Creative Medical's regenerative therapies.
Vericel
VCEL
Mkt Cap1.77B
Vericel Corporation produces autologous cell therapies for treating damaged or diseased tissue, which competes with Creative Medical's approach to tissue regeneration and repair.
Brainstorm Cell Therapeutics
BCLI
Mkt Cap6.74M
Brainstorm Cell Therapeutics Inc. works on developing innovative, autologous stem cell therapies for neurodegenerative diseases, overlapping with Creative Medical's interest in regenerative treatments.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics AG is focused on gene editing, a cutting-edge area of biotechnology that competes with Creative Medical's regenerative medicine and cell therapy techniques.
Editas Medicine
EDIT
Mkt Cap276.95M
Editas Medicine, Inc. is involved in gene editing technology, which represents a competitive approach to Creative Medical's focus on regenerative and cell-based therapies.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics, Inc. specializes in CRISPR/Cas9 gene editing, competing in the innovative treatment space that includes Creative Medical's regenerative medicine efforts.
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
Sangamo Therapeutics, Inc. applies genomic medicine to develop gene therapies, directly competing with Creative Medical's focus on innovative, cell-based therapeutic solutions.

About

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Show more...
CEO
Mr. Timothy Warbington
Employees
4
Country
US
ISIN
US22529Y4089

Listings

XNAS
US
CELZ
BOATS
BOATS
CELZ.BOATS

0 Comments

Share your thoughts

FAQ

What is Creative Medical Technology stock price today?▼
The current price of CELZ is $2.05 USD — it has increased by +3.19% in the past 24 hours. Watch Creative Medical Technology stock price performance more closely on the chart.
What is Creative Medical Technology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Creative Medical Technology stocks are traded under the ticker CELZ.
Is Creative Medical Technology stock price growing?▼
CELZ stock has risen by +4.23% compared to the previous week, the month change is a +10.4% rise, over the last year Creative Medical Technology has showed a -11.11% decrease.
What is Creative Medical Technology market cap?▼
Today Creative Medical Technology has the market capitalization of 5.3M
When is the next Creative Medical Technology earnings date?▼
Creative Medical Technology is going to release the next earnings report on June 03, 2026.
What were Creative Medical Technology earnings last quarter?▼
CELZ earnings for the last quarter are -0.37 USD per share, whereas the estimation was -0.37 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Creative Medical Technology revenue for the last year?▼
Creative Medical Technology revenue for the last year amounts to 22,000 USD.
What is Creative Medical Technology net income for the last year?▼
CELZ net income for the last year is -10.99M USD.
How many employees does Creative Medical Technology have?▼
As of April 04, 2026, the company has 4 employees.
In which sector is Creative Medical Technology located?▼
Creative Medical Technology operates in the Health Care sector.
When did Creative Medical Technology complete a stock split?▼
The last stock split for Creative Medical Technology was on June 12, 2023 with a ratio of 1:10.
Where is Creative Medical Technology headquartered?▼
Creative Medical Technology is headquartered in Phoenix, US.